Insulin Detemir Causes Lesser Weight Gain in Comparison to Insulin Glargine: Role on Hypothalamic NPY and Galanin
Objective. Compared with other insulin analogues, insulin detemir induces less weight gain. This study investigated whether this effect was achieved by influencing the hypothalamic appetite regulators neuropeptide Y (NPY) and galanin (GAL). Methods. Type 2 diabetic rat models were established with...
Saved in:
Main Authors: | Mohammad Ishraq Zafar, Cuining Hu, Danfeng Liu, Raja Adeel Shafqat, Feng Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2014/458104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
by: Ilhan Satman, et al.
Published: (2013-08-01) -
Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats
by: Zhenwen Zhang, et al.
Published: (2016-01-01) -
Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries
by: David Beran, et al.
Published: (2025-01-01) -
A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes
by: Shuo Lin, et al.
Published: (2018-01-01) -
Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis
by: Mathilde Sollier, et al.
Published: (2019-01-01)